Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

202
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
202
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

330
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
330
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.7K
Infection01:20

Infection

8.7K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
8.7K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

189
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
189
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

92
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
92

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular Evaluation of Rifampicin and Isoniazid Resistance in Pulmonary Tuberculosis Using Cartridge-Based Nucleic Acid Amplification Test and Line Probe Assay.

Cureus·2026
Same author

Comparative evaluation of Truenat® MTB Plus assay and GeneXpert® MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary tuberculosis: A pilot study.

Journal of microbiological methods·2026
Same author

Pneumococcal meningitis among hospitalised children after introduction of pneumococcal conjugate vaccine in India: a sentinel hospital surveillance (2019-2022).

The Lancet regional health. Southeast Asia·2026
Same author

Arginine deiminase-polymeric hybrid nanoconjugates: A potential biodrug for targeted treatment of arginine auxotrophic cancers.

International journal of biological macromolecules·2025
Same author

Plant-derived Cyclotides in Immunomodulation and their Therapeutic Potential.

Protein and peptide letters·2025
Same author

Detection of MPT-64 protein in pleural tuberculosis cases by magnetic bead-gold nanoparticle-PCR amplified immunoassay.

Future microbiology·2024

Related Experiment Video

Updated: Sep 11, 2025

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

531

Synbiotics: An Emerging Frontier in Infectious Diseases Control.

Nikita Jangra1, Nikita Chahar1, Aparna Parmar2

  • 1Medical Microbiology and Bioprocess Technology Laboratory, Department of Microbiology, Maharshi Dayanand University, Rohtak, Haryana, 124001, India.

Probiotics and Antimicrobial Proteins
|August 13, 2025
PubMed
Summary
This summary is machine-generated.

Synbiotics, a blend of prebiotics and probiotics, help restore gut balance and manage infectious diseases. They offer a promising alternative or supplement to antibiotics by fighting pathogens and supporting immune health.

Keywords:
Clinical applicationsHuman healthInfectious diseasesPrebioticsProbioticsSynbiotics

More Related Videos

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
07:22

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Published on: August 19, 2021

3.1K
Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface
10:24

Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface

Published on: July 4, 2018

11.8K

Related Experiment Videos

Last Updated: Sep 11, 2025

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

531
Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
07:22

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings

Published on: August 19, 2021

3.1K
Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface
10:24

Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface

Published on: July 4, 2018

11.8K

Area of Science:

  • Microbiology
  • Immunology
  • Gastroenterology

Background:

  • The human gut microbiome plays a vital role in health, influencing digestion, nutrient absorption, and immunity.
  • Gut microbiota dysbiosis is linked to infectious disease development.
  • Synbiotics (prebiotics + probiotics) are increasingly used for immune and gastrointestinal health.

Purpose of the Study:

  • To explore the potential of synbiotics as alternatives or adjuncts to antibiotics for infectious diseases.
  • To detail available synbiotic formulations and their mechanisms of action.
  • To address challenges and recent advancements in synbiotic efficacy.

Main Methods:

  • Review of scientific literature on synbiotics and infectious diseases.
  • Analysis of synbiotic formulations and their clinical applications.
  • Discussion of mechanisms by which synbiotics antagonize pathogens.

Main Results:

  • Synbiotics effectively restore gut eubiosis and modulate the microbiome.
  • Dietary synbiotics show promise in treating infections like hepatitis, gastroenteritis, and sepsis.
  • Synbiotics combat pathogens by maintaining homeostasis, competing for resources, producing antimicrobials, and stimulating immunity.

Conclusions:

  • Synbiotics are potent in managing infectious diseases by restoring gut microbiota homeostasis.
  • They offer a viable alternative or adjunct to antibiotic therapy.
  • Ongoing research aims to enhance synbiotic efficacy through novel approaches.